As of Nov 21, 2024, the CONMED stock's P/E ratio is 16.75. This takes into account the latest EPS of $4.28 and stock price of $71.71. The PE ratio has decreased by 44% from its last 4 quarters average of 30.1.
The PE ratio of CONMED has averaged 244.4 over the last ten years. The current price-to-earnings ratio of 16.75 is 93% less than the historical average. Analyzing the last ten years, CNMD's PE ratio reached its highest point in the Sep 2020 quarter at 3,933.5, when the price was $78.67 and the EPS was $0.02. The lowest point was recorded in the Sep 2024 quarter, when it reached 16.8 with a price of $71.92 and an EPS of $4.28.
Maximum annual increase: 206.53% in 2020
Maximum annual decrease: -80.48% in 2021
Year | PE ratio | Change |
---|---|---|
2023 | 52.15 | N/A |
2022 | N/A | N/A |
2021 | 66.24 | -80.48% |
2020 | 339.39 | 206.53% |
2019 | 110.72 | 150.05% |
2018 | 44.28 | 72.9% |
2017 | 25.61 | -69.27% |
2016 | 83.34 | 108.09% |
2015 | 40.05 | 4.22% |
2014 | 38.43 | 17.56% |
CNMD's current PE ratio is under its 3, 5 and 10-year averages.
CNMD's PE ratio is below its peer stocks JNJ and SYK. CONMED's current PE ratio of 16.75 is less than the average of its peers, which is 41.66.
Stock name | PE ratio | Market cap |
---|---|---|
CNMD CONMED Corp | 16.75 | $2.22B |
JNJ Johnson & Johnson | 25.79 | $374.39B |
MDT Medtronic plc | 28.44 | $108.68B |
TFX Teleflex Inc | 37.68 | $8.85B |
SYK Stryker Corp | 41.37 | $148.73B |
BSX Boston Scientific Corp | 75 | $134.86B |
IART Integra Lifesciences Holdings Corp | N/A | $1.77B |
CNMD's price to earnings ratio is 16.75 as of Nov 21, 2024.
As an average over the last 3 years, CNMD stock has a PE ratio of 43.65.
As an average over the last 5 years, CNMD stock has a PE ratio of 474.91.
Over the last ten years, the Sep 2020 quarter recorded the highest quarterly PE ratio at 3,933.5.
CNMD's price to earnings ratio is currently 93% below its 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Nov 21, 2024), CONMED's share price is $71.71. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $4.28. Therefore, CONMED's price to earnings ratio for today is 16.75. PE RATIO(16.75) = STOCK PRICE($71.71) / TTM EPS($4.28)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.